Latest Updates

Articles posted in the "Latest Updates" are compiled and published into a bulletin quarterly.

Previously published articles are available within the Noridian Bulletins webpage. Exclusions to this include time-sensitive announcements such as: Noridian and CMS educational Events, Ask-the-Contractor Teleconferences, and claims processing downtime.

The information included in the Latest Updates is also available by subscribing to the Noridian email list. Medicare news, regulations, workshop notices, and other related notifications will be delivered to you each week. Register Now!

Articles Source Posted
Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing (A57268) - R4 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Proteomics Testing (A59641) - R11 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R18 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R25 - Effective October 1, 2025 Oct 23, 2025
Policy Revision(s) for Local Coverage Determinations and Associated Billing and Coding Articles - Effective October 23, 2025 Oct 23, 2025
COVID-19 Vaccine Fee Update Mass Adjustment - Resolved 10/22/25 Alert Oct 22, 2025
Telehealth - Effective October 1, 2025 Oct 22, 2025
MLN Connects Special Edition: Claims Hold Update - October 21, 2025 Oct 21, 2025
Medicare B News JE October 2025 Bulletin - Now Available Oct 20, 2025
Billing and Coding: Wound Care and Debridement - Provided by a Therapist, Physician, NPP or as Incident-to Services (A53296) - R7 - Effective October 01, 2015 Oct 16, 2025
MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (L39373) - R1 - Effective August 6, 2023 Oct 16, 2025
MolDX: Pharmacogenomics Testing (L38335) - R4 - Effective October 2, 2025 Oct 16, 2025
Billing and Coding: Lab: Bladder/Urothelial Tumor Markers (A55028) - R10 - Effective October 1, 2025 Oct 16, 2025
MolDX: Melanoma Risk Stratification Molecular Testing (L37750) - R8 - Effective June 26, 2025 Oct 16, 2025
Policy Revision(s) for Local Coverage Determinations and Associated Billing and Coding Articles - Effective October 16, 2025 Oct 16, 2025
Billing and Coding: Routine Foot Care (A57954) - R17 - Effective October 1, 2025 Oct 16, 2025
MLN Connects Special Edition: Claims Hold Update - October 15, 2025 Oct 15, 2025
Drugs and Biologicals Outpatient Overview and Billing Webinar - 11/18/2025 Oct 15, 2025
Drugs and Biologicals Outpatient Documentation and Post-Pay Review Webinar - 11/25/2025 Oct 15, 2025
Ambulatory Surgical Center Prior Authorization Webinar - 11/18/2025 Oct 15, 2025
PECOS: Application Data Entry Webinar - 11/19/2025 Oct 15, 2025
Prior Authorization of Repetitive, Scheduled Non-Emergent Ambulance Transport (RSNAT) Webinar - 11/20/2025 Oct 15, 2025
End Stage Renal Disease (ESRD) Webinar - 11/20/2025 Oct 15, 2025
Outpatient Therapy Services: Clarifying Qualifications for Speech-Language Pathologists Oct 09, 2025
Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) (L39810) - R2 - Effective April 17, 2025 Oct 09, 2025
MolDX: Pigmented Lesion Assay (L38151) - R2 - Effective June 20, 2024 Oct 09, 2025
MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer (L37897) - R4 - Effective October 14, 2021 Oct 09, 2025
ProMark Risk Score (L36704) - R6 - Effective December 30, 2021 Oct 09, 2025
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (L39923) - R2 - Effective August 17, 2025 Oct 09, 2025
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (L39001) - R5 - Effective July 3, 2025 Oct 09, 2025